Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
82.81
Dollar change
+0.94
Percentage change
1.15
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.K. Return% 1Y59.40% Total Holdings2 Perf Week17.05%
SponsorPrecidian ETF Type Tagssingle-asset Return% 3Y- AUM818.76K Perf Month17.36%
Fund Family Bond Type TagsGSK Return% 5Y- NAV/sh Perf Quarter22.10%
Index- Average Maturity Tagshedge-currency Return% 10Y 52W High81.88 1.13% Perf Half Y56.98%
Index Weighting Commodity Type Tags- Return% SI 52W Low48.14 72.01% Perf YTD21.41%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.89% 0.72% Perf Year64.80%
Dividend TTM0.79 (0.95%) ESG Type Tags- Flows% 3M0.00% ATR (14)1.46 Perf 3Y-
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)82.31 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta-0.32 Perf 10Y-
Expense0.19% Growth/Value SMA2016.54% Flows% 3Y Rel Volume1.00 Prev Close81.86
Inverse/Leveraged Market Cap SMA5018.91% Flows% 5Y Avg Volume0.27K Price82.81
IPOJan 07, 2025 Option/ShortNo / Yes SMA20037.90% Trades Volume272 Change1.15%
GSK plc ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of GSK plc in its local market. The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of GSK plc (the "Company"). The series will not invest directly in the company. The fund is non-diversified.